OWLT
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Owlet maintains a Neutral rating with a composite score of 48.5, reflecting an environment where positive fundamental aspects are counterbalanced by challenging market and regulatory contexts. The fundamentals pillar is the strongest, driven by robust gross margins, with regulatory and market pillars trailing in support. The overall conviction rating stands at 1 out of 5, indicating low confidence in significant market-beating performance at this time. Given the company's stretched financial condition, caution is advised when considering the broader financial landscape.
Revenue growth year-over-year shows moderate improvement, though operating margins remain firmly negative. Primary regulatory filings fail to suggest any immediate positive enforcement developments, contributing to a lukewarm regulatory outlook. Despite solid gross margin metrics, the ongoing net income losses challenge long-term sustainability. The company does not benefit from recent market price advancements, with institutional pricing feeds lacking updated quote data, which points to subdued market interest. Filing cadences similarly reflect this lethargy, with incomplete timely submissions.
Looking forward, investors should monitor fundamental developments closely. The company's gross margin potential enables a buffer against adverse shifts, providing a foothold in navigating fiscal uncertainties. Enhancements in revenue growth or significant operating margin improvements would be pivotal in strengthening Owlet's financial posture. Keeping an eye on how Owlet manages its financial condition in upcoming fiscal periods will be crucial for investors assessing new entry points. The fundamental pillar remains the strongest driver, and any shifts in this area may signal a broader strategic turn for Owlet.
- IR / PR agency
- Hannah Cranston Media (HCM)
- IR email
- ir@owletcare.com
- IR page
- Investor relations
- Headquarters
- 2940 WEST MAPLE LOOP DRIVE, SUITE 203, LEHI, UT, 84048
- Phone
- 8443345330
- CEO
- Kurt Workman
- CFO
- Amanda Twede Crawford
- Auditor
- Salt Lake City
- SEC CIK
- 1816708
- Website
- Company website
- Market cap
- $177.0M
- Enterprise value
- $173.2M
- Price to book
- 7.69
- Price to sales
- 1.65
- EV / EBITDA
- -0.61
- Revenue (TTM)
- $107.1M
- Gross profit (TTM)
- $54.4M
- EBITDA
- $-10.9M
- Operating margin
- -24.4%
- Profit margin
- -43.0%
- Rev growth YoY
- 6.4%
- Return on equity
- -526.2%
- Return on assets
- -10.0%
- EPS (TTM)
- $-2.57
- EPS est. current year
- $0.13
- Wall St. target price
- $13.00
- Shares outstanding
- 29.1M
- Insider ownership
- 10.5%
- Institutional ownership
- 74.5%
- Beta
- 1.84
- Full-time employees
- 108
- GICS sector
- Healthcare
- GICS industry
- Medical Devices
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for OWLT (OWLT)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for OWLT (OWLT), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for OWLT are maintained by Cannabis Investor News and refreshed throughout the trading day.